| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |